NCT00800553View on ClinicalTrials.gov

fMRI-behavioral Study of Cholinergic Augmentation With Donepezil in Healthy Sleep Deprived Adults

PHASE4CompletedINTERVENTIONAL

Enrollment

43

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions

Sleep Deprivation

Interventions

DRUG

donepezil

5mg o.m. p.o. for approx. 2 weeks

DRUG

Placebo

5mg of placebo for approx. 2 weeks

Trial Locations (1)

169611

Cognitive Neuroscience Laboratory, Duke-NUS Graduate Medical School, Singapore

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

Duke-NUS Graduate Medical School

OTHER

NCT00800553 - fMRI-behavioral Study of Cholinergic Augmentation With Donepezil in Healthy Sleep Deprived Adults | Biotech Hunter | Biotech Hunter